Table 1.
Distribution of females and males in age groups in the study population (N = 10037).
Table 2.
Distribution of chronic health conditions and medications at baseline, stratified by age and sex (%).
Fig 1.
Incident (cumulative) multimorbidity (%) during 15-year trajectory stratified by sex.
Fig 2.
Age and age group effects on multimorbidity over time stratified by sex—Females (a) and males (b) (Y-axis: Predicted probability (proportion) of multimorbidity stratified for sex and age-groups (1 = 0–24 year; 2 = 25–44 year; 3 = 45–64 year; 4 = 65 year and older) during 15-year trajectory; X-axis: Age as time-varying variable, including a squared age-term).
Table 3.
Prevalence in terms of the crude incidence proportion of multimorbidity (%) and its relative increase (ratio of prevalence in 2014 versus 2000).
Fig 3.
Predicted probability (cumulative) incident multimorbidity stratified according to medical history of multimorbidity at baseline.
Fig 4.
Predicted cumulative proportion of polypharmacy over the 15-year trajectory stratified by sex.
Fig 5.
Predicted cumulative proportion of polypharmacy during 15-year trajectory stratified by sex and age.
Table 4.
Comparison of the prevalence (%) of polypharmacy (PP) at the start and the end of the 15-year trajectory in the fixed cohort in absolute terms and relatively.
Fig 6.
Predicted probability of polypharmacy stratified by presence of multimorbidity at baseline (pre) in combination with emergence of incident multimorbidity during 15-year trajectory (pro).